Technical Analysis for ATRC - AtriCure, Inc.

Grade Last Price % Change Price Change
grade A 30.83 0.49% 0.15
ATRC closed up 0.49 percent on Wednesday, December 12, 2018, on 45 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical ATRC trend table...

Date Alert Name Type % Chg
Dec 12 50 DMA Resistance Bearish 0.00%
Dec 12 NR7 Range Contraction 0.00%
Dec 12 Stochastic Reached Oversold Weakness 0.00%
Dec 12 Strong but Oversold Other 0.00%
Dec 12 Inside Day Range Contraction 0.00%
Dec 12 Strong, Oversold and Reversal Signs Reversal 0.00%
Dec 12 Oversold Stochastic Weakness 0.00%
Dec 11 50 DMA Resistance Bearish 0.49%
Dec 11 MACD Bearish Centerline Cross Bearish 0.49%
Dec 10 50 DMA Resistance Bearish -1.41%

Older signals for ATRC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
AtriCure, Inc., a medical device company, develops, manufactures, and sells cardiac surgical ablation systems designed to create precise lesions or scars in cardiac tissue. It provides isolator bipolar radio-frequency ablation clamps that are used for ablation during open-heart procedures; and ablation and sensing unit, a compact power generator that provides the radio-frequency (RF) energy for its clamps, multifunctional pens, and coolrail linear ablation devices. The company also offers AtriCure switch box, a compact switch box, which offers the technology needed for the dual pulsing electrodes in isolator synergy clamps; isolator multifunctional pens that enable surgeons to evaluate cardiac arrhythmias, as well as to perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and coolrail linear ablation device, a disposable linear RF ablation device that allows physicians to create an expanded cardiac ablation lesion set during minimally invasive procedures. In addition, it provides cryoablation system, which is used for AF ablation treatment during certain open-heart procedures; and AtriClip System that is designed to exclude the left atrial appendage by implanting the device during concomitant open surgical procedures. Further, the company sells technologies, including Lumitip dissector to separate tissues to provide access to anatomical structures that are targeted for ablation; and the MicroPace ORLab system, a stimulating, mapping, and recording system, which enables physicians to confirm that the ablation lines being created are forming electrical barriers or lines of block. The company sells its products to hospitals and medical centers through independent distributors and direct sales personnel worldwide. AtriCure, Inc. is headquartered in West Chester, Ohio.
Is ATRC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 36.49
52 Week Low 14.88
Average Volume 282,754
200-Day Moving Average 27.7361
50-Day Moving Average 31.6506
20-Day Moving Average 31.895
10-Day Moving Average 32.173
Average True Range 1.3539
ADX 10.18
+DI 17.1576
-DI 19.1806
Chandelier Exit (Long, 3 ATRs ) 30.3283
Chandelier Exit (Short, 3 ATRs ) 34.2217
Upper Bollinger Band 33.7398
Lower Bollinger Band 30.0502
Percent B (%b) 0.21
BandWidth 11.567957
MACD Line -0.1355
MACD Signal Line 0.074
MACD Histogram -0.2095
Fundamentals Value
Market Cap 1.06 Billion
Num Shares 34.3 Million
EPS -1.02
Price-to-Earnings (P/E) Ratio -30.23
Price-to-Sales 4.44
Price-to-Book 4.57
PEG Ratio -1.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.32
Resistance 3 (R3) 32.46 32.12 32.07
Resistance 2 (R2) 32.12 31.74 32.04 31.98
Resistance 1 (R1) 31.47 31.50 31.30 31.33 31.90
Pivot Point 31.13 31.13 31.04 31.05 31.13
Support 1 (S1) 30.48 30.75 30.31 30.34 29.76
Support 2 (S2) 30.14 30.51 30.06 29.68
Support 3 (S3) 29.49 30.14 29.59
Support 4 (S4) 29.35